VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT
Clinical trial NCT06447090 · RECRUITING
Trial details
- NCT number
- NCT06447090
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-12
- Primary completion
- 2027-05-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.